DOCSLIB.ORG

Swiss Small and Mid-Cap Equities – Consistent Value Creation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Swiss Small and Mid-Cap Equities – Consistent Value Creation Swiss Small and Mid-Cap Equities – Consistent value creation White Paper For professional investors in Switzerland or professional investors as defined by the relevant laws Asset Management | November 2020 Performance of major equity markets (%) Key points 100 ■ The Swiss economy has once again proven its 80 resilience during the Covid-19 pandemic, as 60 reflected by year-to-date outperformance in the 40 Swiss equity market and also its small and mid- 20 cap segment. 0 ■ Several Swiss companies across all market-cap -20 segments have benefited from the disruption -40 caused by the pandemic, since they have CHF CHF USD USD USD EUR EUR EUR GBP exposure to underlying long-term trends that SPI SPI MSCI S&P S&P MSCI MSCI DAX FTSE Extra AC 500 MidcapEurope Europe Mid 250 have been accelerated by the crisis. World 400 Small Cap ■ However, the strongest argument for exposure to Cap Swiss equities within a diversified equity YTD 5Y portfolio remains the consistent long-term Sources: UBP and, Bloomberg Finance LP. Data as of September 2020. Past performance is not a guide to current or outperformance of Swiss equities, driven by their future results. superior value-creation and ESG profiles. ■ An active investment approach, driven by The 2020 EPS growth estimate for global equities has fundamentals and supported by extensive remained steady at around -19% over the past few expertise and knowledge of the market, has led months, while the 2021 estimate now stands at almost to an impressive track record and substantial +30%. Expected regional earnings growth rates for 2020 AuM growth for UBP’s Swiss equity franchise range from +0% for China to -39% for the UK and the over the last 14 years. eurozone; for Switzerland, analysts expect a comparatively small 10% decline in EPS. Swiss companies are innovation leaders in various Switzerland and Covid-19 industries, probably most visibly in medical technologies. As in previous crises, the safe-haven status of the Swiss Close to 700 Swiss companies specialise in this field, franc and an inflation rate of only 0.2% (as of the end of ranging from big players such as Novartis, Roche and 2019) have helped Switzerland weather the storm in the past Lonza, to listed small- and mid-sized companies such as few months. The country has an independent central bank Tecan, Vifor Pharma and Straumann, as well as a host of that operates free of political pressure: the Swiss National privately-owned companies. Bank has been working with negative interest rates since In the small- and mid-cap segment, IT specialist Logitech 2015 and has intervened in foreign exchange markets when and medical lab supplier Tecan have been among the necessary to absorb external shocks and ease upside strongest contributors to the SPI Extra’s year-to-date pressure on the Swiss franc. performance. As well as these companies, several others Switzerland’s fiscal stability allowed the country’s parliament in the Swiss market have benefited from positive to act quickly and adopt a substantial aid package of CHF newsflow, across various sectors and market-cap 57 billion to support the domestic economy. In addition, the categories. Swiss loan programme, developed through close collaboration between the government and Swiss banks to Consistent, long-term value creation offer SMEs quick and easy access to loans to cover their immediate liquidity needs, has won international acclaim. Despite its small size in geographical terms, Switzerland ranks fifth in the MSCI AC World index, with a 3% weighting and a In the first few volatile months of 2020, movements in the total market capitalisation over CHF 1.3 trillion as of June Swiss equity market reflected the solid standing of both the 2020. Swiss equities offer a lower correlation to global equities country and its companies: Switzerland outperformed most and are supported by a strong underlying currency, which can major global equity markets by limiting the downside while benefit investors seeking real returns. Most sectors and at the same time participating in strong rallies. The SPI Extra companies have adapted to the currency’s strength; for – Switzerland’s small- and mid-cap index – has shown instance, the pharmaceutical industry, which accounts for a similar resilience compared with major global and regional significant share of exports, boasts strong pricing power as it indices, both year-to-date and over the longer term. is less affected by short-term economic fluctuations. Meanwhile, some small- and mid-cap companies are indispensable to their large global customers and have cemented leading market positions in their respective industries. Union Bancaire Privée, UBP SA 2 | 5 Global industry leaders in the Swiss SMID segment capital in the Swiss & Global Equity team’s investment framework. Historically, and until recently, Switzerland has consistently delivered CFROI significantly in excess of other regional markets. It is worth noting that the quality and value- VAT Bachem Interoll Barry creation potential of the small- and mid-cap segment has been Group Global leader in Global Callebaut improving over recent years, as reflected by its strong Dominant the market World's leading global manufacturing leader in manufacturer outperformance over the period. market of peptides, drum of high-quality share of which are key motors chocolate and As passive investment options in Swiss equities are 41% in ingredients in used in cocoa products valves used some of the internal somewhat limited and concentrated on large caps, an active in vacuum world's best- logistics investment approach is the best way to gain exposure to the applications selling drugs solutions small- and mid-cap segment’s substantial value-creation Sources: UBP and company reports. For illustrative purposes only. This potential. As the segment receives much less coverage from is not an indication to buy or sell. Data as of June 2020. sell-side analysts than SMI stocks, there are also ample alpha As mentioned previously, Swiss equities, especially in the opportunities that can be exploited by active managers with small- and mid-cap segment, tend to outperform global the experience and expertise of UBP’s Swiss equity franchise. equities over both short and longer time periods. When we Consistent value creation factor in relative volatility, Swiss equities are even more attractive, as they deliver one of the highest risk-adjusted returns of any major equity market. Long-term outperformance, SPI and SPI Extra vs MSCI AC World 350 SPI SWISS PERFORMANCE IX 300 SPI Extra MSCI AC World Daily TR N 250 200 150 100 Source: Holt, Credit Suisse, UBP, as of 30/06/2020. Past performance is 50 not a guide to current or future results. As of September 2020, UBP’s active Swiss equity strategies 0 – delivered through UCITS and Swiss contractual fund 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2000 structures and built on the CFROI life-cycle framework – had Sources: UBP and Bloomberg Finance LP. Data as of September track records of more than 14 years for the flagship Swiss 2020. Past performance is not a guide to current or future results. Equity strategy (since 30 June 2006) and five years for the Risk-adjusted return matrix of major equity markets, in Swiss Small- and Mid-Cap strategy (since 30 June 2015). local currencies, over 15 years Both strategies show sustained, enhanced value creation compared with their respective benchmarks, as well as CAGR (%) superior ESG profiles relative to global equities. 10 The historical sector breakdown of these strategies shows a consistent and balanced sector allocation over time, while stock selection has always been the main driver of returns for SPI Extra MSCI Europe both of them. A fundamental bottom-up investment process Small Cap SPI S&P 500 MSCI AC is key to delivering superior value creation over both the short 6 MSCI EM World and long term. UBP’s Swiss equity strategies remain well positioned for both short-term momentum and underlying MSCI long-term drivers, without the need to time markets or Europe themes. MSCI Japan 2 10 15 20 25 Volatility (%) Swiss & Global Equity team Union Bancaire Privée, UBP SA Sources: UBP and Bloomberg Finance LP. Total returns shown in local currencies from 30 September 2005 to 30 September 2020. Past Rue du Rhône 96-98 | P.O. Box | CH-1211 Geneva 1 performance is not a guide to current or future results. T +41 58 819 21 11 This consistent outperformance is linked to high levels of value creation, as measured by the positive differential between cash flow return on investment (CFROI) and cost of Please consider the environment before printing. Union Bancaire Privée, UBP SA 3 | 5 Disclaimer This is a marketing document and is intended for informational and/or marketing purposes only. It is confidential and is intended to be used only by the person(s) to whom it was delivered. It may not be reproduced (in whole or in part) or delivered, given, sent or in any other way made accessible, to any other person without the prior written approval of Union Bancaire Privée, UBP SA or any entity of the UBP Group (UBP). This document reflects the opinion of UBP as of the date of issue. This document is for distribution only to persons who are Professional clients in Switzerland or Professional Clients or an equivalent category of investor as defined by the relevant laws (all such persons together being referred to as “Relevant Persons”). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. It is not intended for distribution, publication, or use, in whole or in part, in any jurisdiction where such distribution, publication, or use would be unlawful, nor is it directed at any person or entity at which it would be unlawful to direct such a document.
Load more

Recommended publications
  • Market Notice Date: 14 November 2019 Market Notice Number: 112/2019
    Market Notice Date: 14 November 2019 Market Notice Number: 112/2019 Equiduct Universe Change Please see today's changes below effective 18 November 2019: Trading Reporting MIC Settlement Trading Settlement Tick Size Change/ Security Name ISIN Home Market Symbol Country Currency Currency table Action ABB LTD ABBNz CH0012221716 XSWX EQTB CH CHF CHF ESMA_E Deletion ABB ABBs CH0012221716 XSTO EQTB SE SEK SEK ESMA_E Deletion ADECCO SA ADENz CH0012138605 XSWX EQTC CH CHF CHF ESMA_E Deletion AMS AG AMSz AT0000A18XM4 XSWX EQTC CH CHF CHF ESMA_E Deletion ARYZTA AG ARYNz CH0043238366 XSWX EQTB CH CHF CHF ESMA_E Deletion JULIUS BAER GRUPPE AG BAERz CH0102484968 XSWX EQTC CH CHF CHF ESMA_E Deletion BALOISE-HLDGS BALNz CH0012410517 XSWX EQTC CH CHF CHF ESMA_D Deletion BARRY CALLEBAUT AG BARNz CH0009002962 XSWX EQTC CH CHF CHF ESMA_D Deletion BB BIOTECH BBZAd CH0038389992 XETR EQTB DE EUR EUR ESMA_D Deletion BB BIOTECH BIONz CH0038389992 XSWX EQTB CH CHF CHF ESMA_D Deletion BASILEA PHARMACEUTICA AG BSLNz CH0011432447 XSWX EQTC CH CHF CHF ESMA_D Deletion BUCHER INDUSTRIES BUCNz CH0002432174 XSWX EQTC CH CHF CHF ESMA_D Deletion COMPAGNIE FINANCIERE RICHEMONT CFRz CH0210483332 XSWX EQTC CH CHF CHF ESMA_E Deletion CLARIANT CLNz CH0012142631 XSWX EQTC CH CHF CHF ESMA_E Deletion CEMBRA MONEY BANK AG CMBNz CH0225173167 XSWX EQTC CH CHF CHF ESMA_D Deletion CREDIT SUISSE GROUP AG CSGNz CH0012138530 XSWX EQTC CH CHF CHF ESMA_E Deletion DKSH HOLDING DKSHz CH0126673539 XSWX EQTC CH CHF CHF ESMA_D Deletion DORMA+KABA HOLDING AG DOKAz CH0011795959 XSWX EQTC CH CHF
    [Show full text]
  • Full Portfolio Holdings
    Hartford Multifactor International Fund Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets Merck KGaA 0.000 152 36,115 0.982 Kuehne + Nagel International AG 0.000 96 35,085 0.954 Novo Nordisk A/S 0.000 333 33,337 0.906 Koninklijke Ahold Delhaize N.V. 0.000 938 31,646 0.860 Investor AB 0.000 1,268 30,329 0.824 Roche Holding AG 0.000 74 29,715 0.808 WM Morrison Supermarkets plc 0.000 6,781 26,972 0.733 Wesfarmers Ltd. 0.000 577 25,201 0.685 Bouygues S.A. 0.000 595 24,915 0.677 Swisscom AG 0.000 42 24,651 0.670 Loblaw Cos., Ltd. 0.000 347 24,448 0.665 Mineral Resources Ltd. 0.000 596 23,709 0.644 Royal Bank of Canada 0.000 228 23,421 0.637 Bridgestone Corp. 0.000 500 23,017 0.626 BlueScope Steel Ltd. 0.000 1,255 22,944 0.624 Yangzijiang Shipbuilding Holdings Ltd. 0.000 18,600 22,650 0.616 BCE, Inc. 0.000 427 22,270 0.605 Fortescue Metals Group Ltd. 0.000 1,440 21,953 0.597 NN Group N.V. 0.000 411 21,320 0.579 Electricite de France S.A. 0.000 1,560 21,157 0.575 Royal Mail plc 0.000 3,051 20,780 0.565 Sonic Healthcare Ltd. 0.000 643 20,357 0.553 Rio Tinto plc 0.000 271 20,050 0.545 Coloplast A/S 0.000 113 19,578 0.532 Admiral Group plc 0.000 394 19,576 0.532 Swiss Life Holding AG 0.000 37 19,285 0.524 Dexus 0.000 2,432 18,926 0.514 Kesko Oyj 0.000 457 18,910 0.514 Woolworths Group Ltd.
    [Show full text]
  • Annual Report 2018 19 Table of Content
    FINANCIAL REPORT Annual Report 2018 19 Table of content Letter to shareholders 2 Our product and service offering 6 Strategy and businesses 10 Corporate governance 36 Compensation report 60 Financial review 96 5 year key figures 104 Consolidated financial statements 105 Financial statements of Sonova Holding AG 175 Investor information 188 Corporate Responsibility Report 190 Letter to shareholders Dear shareholders, 2018/19 marked another year of solid financial performance, posting further record levels of sales and profits to which all three businesses contributed. Moreover – and as expected – growth accelerated from the first half-year to the second, driven by the launch of a number of innovative products and solutions. Sonova affirmed its leading position in audiological performance with the release of the Marvel™ technology platform. Marvel takes full advantage of the unique connectivity enabled by our SWORD™ (Sonova Wireless One Radio Digital) chip and combines it with the proven convenience of our rechargeable solutions. We also made significant progress in our retail business, which we have renamed “audiological care” for one simple reason: care is what we deliver. The expert service We have made significant provided by our hearing care professionals adds key value for the consumer. progress in implementing our strategy. Our cochlear implants business launched a series of innovative new products to strengthen its leading position in this expanding market. Robert Spoerry You will find details of these and other strategic initiatives in the “strategy and businesses” section of this report. The global market in which we operate is poised for further growth, as developed countries see increasing demand from the “baby boomer” generation and developing countries begin to bridge the gap in hearing care provision.
    [Show full text]
  • Remuneration
    REMUNERATION 124 Vifor Pharma Ltd. Annual Report 2020 HIGHLIGHTS PEOPLE 126 Chairwoman’s overview 128 Philosophy and approach to remuneration 130 Governance 134 Board and Executive remuneration 139 Remuneration awarded in 2020 and 2019 146 Overview of executive remuneration in 2020 and 2019 147 Outlook: changes in remuneration model for 2021 148 Statutory auditor’s report PORTFOLIO RESPONSIBILITY GOVERNANCE REMUNERATION FINANCE Vifor Pharma Ltd. Annual Report 2020 125 REMUNERATION CHAIRWOMAN’S OVERVIEW The remuneration “programs of Vifor Pharma are designed to support our corporate strategy and to ensure a sustainable performance towards our future objectives.” SUE MAHONY CHAIRWOMAN OF THE REMUNERATION COMMITTEE 126 Vifor Pharma Ltd. Annual Report 2020 HIGHLIGHTS “ We reward entrepreneurial Vifor Pharma’s remuneration philosophy aims to attract and retain highly talented and behaviour that ethical individuals who help us ensure the drives sustainable long-term competitiveness and success of our PEOPLE business, to meet the needs of patients, to performance and look after the interests of our stakeholders and the environment in order to deliver on the long-term value strategy and to sustain profitable growth. This report sets out the remuneration policies for creation.” the Board of Directors and Executive Commit- tee which are designed to help them achieve these goals. A year of unprecedented challenges for Chief Medical Officer and Gregory Oakes as countries and companies around the world President North America. PORTFOLIO has underlined the importance of a strong and transparent remuneration framework. The Remuneration Committee considers Vifor Notwithstanding, as in previous years, Vifor Pharma appropriately positioned to enable it Pharma’s philosophy and approach to remu- to compete successfully with its peers and to neration has remained stable: we reward support its ambitious growth plans.
    [Show full text]
  • Switzerland Fund A-CHF for Investment Professionals Only FIDELITY FUNDS MONTHLY PROFESSIONAL FACTSHEET SWITZERLAND FUND A-CHF 31 AUGUST 2021
    pro.en.xx.20210831.LU0054754816.pdf Switzerland Fund A-CHF For Investment Professionals Only FIDELITY FUNDS MONTHLY PROFESSIONAL FACTSHEET SWITZERLAND FUND A-CHF 31 AUGUST 2021 Strategy Fund Facts The Portfolio Managers are bottom-up investors who believe share prices are Launch date: 13.02.95 correlated to earnings, and that strong earners will therefore outperform. They look to Portfolio manager: Andrea Fornoni, Alberto Chiandetti invest in companies where the market underestimates earnings because their Appointed to fund: 01.03.18, 01.08.11 sustainability is not fully appreciated. They also look for situations where the impact Years at Fidelity: 7, 15 company changes will have on earnings has not been fully recognised by the market. Fund size: CHF366m They aim to achieve a balance of different types of companies, so they can deliver Number of positions in fund*: 36 performance without adding undue risk. Fund reference currency: Swiss Franc (CHF) Fund domicile: Luxembourg Fund legal structure: SICAV Management company: FIL Investment Management (Luxembourg) S.A. Capital guarantee: No Portfolio Turnover Cost (PTC): 0.01% Portfolio Turnover Rate (PTR): 28.92% *A definition of positions can be found on page 3 of this factsheet in the section titled “How data is calculated and presented.” Objectives & Investment Policy Share Class Facts • The fund aims to provide long-term capital growth with the level of income expected Other share classes may be available. Please refer to the prospectus for more details. to be low. • The fund will invest at least 70% in Swiss company shares. Launch date: 13.02.95 • The fund has the freedom to invest outside its principal geographies, market sectors, industries or asset classes.
    [Show full text]
  • FTSE Publications
    2 FTSE Russell Publications FTSE Developed Europe SMID Cap 19 August 2021 Tradable Plus Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.72 UNITED Bureau Veritas S.A. 0.42 FRANCE Gjensidige Forsikring ASA 0.17 NORWAY KINGDOM Campari 0.31 ITALY Gn Store Nordic 0.53 DENMARK AAK 0.18 SWEDEN Carl Zeiss Meditec 0.33 GERMANY Halma 0.66 UNITED Aalberts NV 0.24 NETHERLANDS Castellum 0.32 SWEDEN KINGDOM ABN AMRO Bank NV 0.23 NETHERLANDS Centrica 0.2 UNITED Hargreaves Lansdown 0.39 UNITED Acciona S.A. 0.16 SPAIN KINGDOM KINGDOM Accor 0.32 FRANCE Chr. Hansen Holding A/S 0.43 DENMARK Hays 0.16 UNITED ACS Actividades Cons y Serv 0.3 SPAIN Clariant 0.21 SWITZERLAND KINGDOM Adecco Group AG 0.49 SWITZERLAND Coca-Cola HBC AG 0.33 UNITED HeidelbergCement AG 0.6 GERMANY Adevinta 0.21 NORWAY KINGDOM HelloFresh SE 0.67 GERMANY Admiral Group 0.43 UNITED Cofinimmo 0.21 BELGIUM Helvetia Holding AG 0.18 SWITZERLAND KINGDOM Commerzbank 0.35 GERMANY Hikma Pharmaceuticals 0.27 UNITED Aedifica 0.22 BELGIUM ConvaTec Group 0.25 UNITED KINGDOM Aegon NV 0.34 NETHERLANDS KINGDOM Hiscox 0.18 UNITED KINGDOM Aeroports de Paris 0.17 FRANCE Countryside Properties 0.16 UNITED Holmen AB 0.2 SWEDEN Ageas 0.46 BELGIUM KINGDOM Homeserve 0.17 UNITED Aker BP ASA 0.16 NORWAY Covestro AG 0.54 GERMANY KINGDOM Alfa Laval 0.52 SWEDEN Covivio 0.2 FRANCE Howden Joinery Group 0.3 UNITED Alstom 0.7 FRANCE Croda International 0.64 UNITED KINGDOM KINGDOM Alten 0.18
    [Show full text]
  • Portfolio of Investments
    PORTFOLIO OF INVESTMENTS Variable Portfolio – Partners International Value Fund, September 30, 2020 (Unaudited) (Percentages represent value of investments compared to net assets) Investments in securities Common Stocks 97.9% Common Stocks (continued) Issuer Shares Value ($) Issuer Shares Value ($) Australia 4.2% UCB SA 3,232 367,070 AMP Ltd. 247,119 232,705 Total 13,350,657 Aurizon Holdings Ltd. 64,744 199,177 China 0.6% Australia & New Zealand Banking Group Ltd. 340,950 4,253,691 Baidu, Inc., ADR(a) 15,000 1,898,850 Bendigo & Adelaide Bank Ltd. 30,812 134,198 China Mobile Ltd. 658,000 4,223,890 BlueScope Steel Ltd. 132,090 1,217,053 Total 6,122,740 Boral Ltd. 177,752 587,387 Denmark 1.9% Challenger Ltd. 802,400 2,232,907 AP Moller - Maersk A/S, Class A 160 234,206 Cleanaway Waste Management Ltd. 273,032 412,273 AP Moller - Maersk A/S, Class B 3,945 6,236,577 Crown Resorts Ltd. 31,489 200,032 Carlsberg A/S, Class B 12,199 1,643,476 Fortescue Metals Group Ltd. 194,057 2,279,787 Danske Bank A/S(a) 35,892 485,479 Harvey Norman Holdings Ltd. 144,797 471,278 Demant A/S(a) 8,210 257,475 Incitec Pivot Ltd. 377,247 552,746 Drilling Co. of 1972 A/S (The)(a) 40,700 879,052 LendLease Group 485,961 3,882,083 DSV PANALPINA A/S 15,851 2,571,083 Macquarie Group Ltd. 65,800 5,703,825 Genmab A/S(a) 1,071 388,672 National Australia Bank Ltd.
    [Show full text]
  • Global Equity Fund Description Plan 3S DCP & JRA MICROSOFT CORP
    Global Equity Fund June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA MICROSOFT CORP 2.5289% 2.5289% APPLE INC 2.4756% 2.4756% AMAZON COM INC 1.9411% 1.9411% FACEBOOK CLASS A INC 0.9048% 0.9048% ALPHABET INC CLASS A 0.7033% 0.7033% ALPHABET INC CLASS C 0.6978% 0.6978% ALIBABA GROUP HOLDING ADR REPRESEN 0.6724% 0.6724% JOHNSON & JOHNSON 0.6151% 0.6151% TENCENT HOLDINGS LTD 0.6124% 0.6124% BERKSHIRE HATHAWAY INC CLASS B 0.5765% 0.5765% NESTLE SA 0.5428% 0.5428% VISA INC CLASS A 0.5408% 0.5408% PROCTER & GAMBLE 0.4838% 0.4838% JPMORGAN CHASE & CO 0.4730% 0.4730% UNITEDHEALTH GROUP INC 0.4619% 0.4619% ISHARES RUSSELL 3000 ETF 0.4525% 0.4525% HOME DEPOT INC 0.4463% 0.4463% TAIWAN SEMICONDUCTOR MANUFACTURING 0.4337% 0.4337% MASTERCARD INC CLASS A 0.4325% 0.4325% INTEL CORPORATION CORP 0.4207% 0.4207% SHORT-TERM INVESTMENT FUND 0.4158% 0.4158% ROCHE HOLDING PAR AG 0.4017% 0.4017% VERIZON COMMUNICATIONS INC 0.3792% 0.3792% NVIDIA CORP 0.3721% 0.3721% AT&T INC 0.3583% 0.3583% SAMSUNG ELECTRONICS LTD 0.3483% 0.3483% ADOBE INC 0.3473% 0.3473% PAYPAL HOLDINGS INC 0.3395% 0.3395% WALT DISNEY 0.3342% 0.3342% CISCO SYSTEMS INC 0.3283% 0.3283% MERCK & CO INC 0.3242% 0.3242% NETFLIX INC 0.3213% 0.3213% EXXON MOBIL CORP 0.3138% 0.3138% NOVARTIS AG 0.3084% 0.3084% BANK OF AMERICA CORP 0.3046% 0.3046% PEPSICO INC 0.3036% 0.3036% PFIZER INC 0.3020% 0.3020% COMCAST CORP CLASS A 0.2929% 0.2929% COCA-COLA 0.2872% 0.2872% ABBVIE INC 0.2870% 0.2870% CHEVRON CORP 0.2767% 0.2767% WALMART INC 0.2767%
    [Show full text]
  • MSCI Switzerland Small Cap Index (CHF) (GROSS)
    MSCI Switzerland Small Cap Index (CHF) The MSCI Switzerland Small Cap Index is designed to measure the performance of the small cap segment of the Swiss equity market. With 85 constituents, the index represents approximately 14% of the free float-adjusted market capitalization in Switzerland. CUMULATIVE INDEX PERFORMANCE — GROSS RETURNS (CHF) ANNUAL PERFORMANCE (%) (AUG 2006 – AUG 2021) MSCI Year Switzerland MSCI World MSCI Europe Small Cap Small Cap 400 MSCI Switzerland Small Cap 2020 13.34 6.32 -3.31 MSCI World Small Cap 361.59 2019 29.77 24.54 22.38 MSCI Europe 2018 -25.26 -12.48 -13.33 300 2017 36.54 18.11 21.04 271.92 2016 11.60 14.99 1.76 2015 13.70 0.86 -1.62 200 2014 8.62 14.32 5.38 2013 34.55 29.15 22.38 152.39 2012 14.34 15.65 17.40 2011 -24.11 -8.41 -10.22 100 2010 30.39 14.12 -5.79 2009 30.61 40.59 32.88 2008 -43.62 -45.10 -49.31 0 2007 8.61 -6.21 6.10 Aug 06 Nov 07 Feb 09 May 10 Aug 11 Nov 12 Feb 14 May 15 Aug 16 Nov 17 Feb 19 May 20 Aug 21 INDEX PERFORMANCE — GROSS RETURNS (%) (AUG 31, 2021) FUNDAMENTALS (AUG 31, 2021) ANNUALIZED Since 1 Mo 3 Mo 1 Yr YTD 3 Yr 5 Yr 10 Yr Dec 29, 2000 Div Yld (%) P/E P/E Fwd P/BV MSCI Switzerland Small Cap 3.20 10.19 36.21 23.49 11.64 13.96 14.06 8.93 1.56 59.37 30.08 2.95 MSCI World Small Cap 3.56 3.92 44.61 21.40 9.99 12.41 13.89 7.33 1.46 34.31 20.09 2.17 MSCI Europe 2.61 3.93 32.09 20.32 8.35 9.21 9.44 2.58 2.44 20.57 15.85 2.18 INDEX RISK AND RETURN CHARACTERISTICS (AUG 31, 2021) ANNUALIZED STD DEV (%) 2 SHARPE RATIO 2 , 3 MAXIMUM DRAWDOWN Turnover Since 1 3 Yr 5 Yr 10 Yr 3 Yr 5 Yr 10 Yr Dec 29, (%) Period YYYY-MM-DD (%) 2000 MSCI Switzerland Small Cap 3.38 18.32 15.11 13.82 0.74 1.00 1.06 0.55 61.59 2007-07-04—2009-03-09 MSCI World Small Cap 13.33 22.77 18.29 15.39 0.57 0.78 0.96 0.46 62.67 2007-06-19—2009-03-09 MSCI Europe 2.07 18.23 15.46 14.17 0.57 0.70 0.75 0.22 62.95 2007-07-16—2009-03-09 1 Last 12 months 2 Based on monthly gross returns data 3 Based on ICE LIBOR 1M The MSCI Switzerland Small Cap Index was launched on Jan 01, 2001.
    [Show full text]
  • FTSE Developed Europe
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Europe Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG 0.01 GERMANY Avast 0.03 UNITED Cnp Assurance 0.02 FRANCE 3i Group 0.14 UNITED KINGDOM Coca-Cola HBC AG 0.06 UNITED KINGDOM Aveva Group 0.05 UNITED KINGDOM A P Moller - Maersk A 0.1 DENMARK KINGDOM Coloplast B 0.19 DENMARK A P Moller - Maersk B 0.15 DENMARK Aviva 0.19 UNITED Colruyt 0.03 BELGIUM A2A 0.03 ITALY KINGDOM Commerzbank 0.07 GERMANY Aalberts NV 0.05 NETHERLANDS AXA 0.43 FRANCE Compagnie Financiere Richemont SA 0.55 SWITZERLAND ABB 0.51 SWITZERLAND B&M European Value Retail 0.06 UNITED Compass Group 0.33 UNITED KINGDOM ABN AMRO Bank NV 0.04 NETHERLANDS KINGDOM BAE Systems 0.21 UNITED Acciona S.A. 0.03 SPAIN Continental 0.14 GERMANY KINGDOM Accor 0.06 FRANCE ConvaTec Group 0.05 UNITED Baloise 0.06 SWITZERLAND Ackermans & Van Haaren 0.03 BELGIUM KINGDOM Banca Mediolanum 0.02 ITALY ACS Actividades Cons y Serv 0.06 SPAIN Covestro AG 0.1 GERMANY Banco Bilbao Vizcaya Argentaria 0.36 SPAIN Adecco Group AG 0.09 SWITZERLAND Covivio 0.04 FRANCE Banco Santander 0.58 SPAIN Adevinta 0.04 NORWAY Credit Agricole 0.14 FRANCE Bank Pekao 0.03 POLAND Adidas 0.63 GERMANY Credit Suisse Group 0.22 SWITZERLAND Bankinter 0.03 SPAIN Admiral Group 0.08 UNITED CRH 0.35 UNITED Banque Cantonale Vaudoise 0.02 SWITZERLAND KINGDOM KINGDOM Barclays 0.35 UNITED Adyen 0.62 NETHERLANDS Croda International 0.12 UNITED KINGDOM KINGDOM Aegon NV 0.06 NETHERLANDS Barratt Developments 0.09 UNITED Cts Eventim 0.03 GERMANY Aena SME SA 0.1 SPAIN KINGDOM Cyfrowy Polsat SA 0.02 POLAND Aeroports de Paris 0.03 FRANCE Barry Callebaut 0.07 SWITZERLAND Daimler AG 0.66 GERMANY Ageas 0.09 BELGIUM BASF 0.64 GERMANY Danone 0.37 FRANCE Ahold Delhaize 0.26 NETHERLANDS Bayer AG 0.53 GERMANY Danske Bank A/S 0.1 DENMARK AIB Group 0.02 IRELAND Bechtle 0.04 GERMANY Dassault Aviation S.A.
    [Show full text]
  • SO AR 11 12 EN WEB[1].Pdf
    That’s the mandate for Sonova’s two main businesses – hearing instruments and hearing implants. We pursue innovation in its broadest brand sense: innovation in products and processes, right across all our activities; innovation in what we make; inno­ portfolio vation in how we make it – and how Unitron Phonak Advanced Bionics we sell it. At the core of our innovation strategy is a rich pipeline of new products. hearing instruments hearing instruments cochlear implants Our goal is to give our customers and end­users enhanced, tangible bene­ Unitron is a global organization Built with the highest techno- Putting the patient first, Advan- built on strong, personal relation- logical standards, providing ced Bionics brings continuous fits. This is achieved by combining our ships with hearing care pro- optimum speech comprehen- innovation to the remarkable fessionals to improve the lives sibility in a wide range of cochlear implant technology, of people with hearing loss. sound conditions. Phonak also delivering the promise of clear, know­how with continuous feedback Distributing a full line of hearing provides wireless commu- high-resolution sound and instruments to customers in nication systems for audiological optimal speech understanding from the users of our hearing solutions, over 60 countries, Unitron has and other applications, as to children and adults with a proven track record of de- well as hearing protection sys- significant hearing loss. veloping technological innova- tems. The product range now as well as the hearing care profes­ tions that provide natural includes the Lyric brand: the sound with exceptional speech world’s first and only extended- understanding, and a relent- wear hearing instrument, sionals who serve them.
    [Show full text]
  • Factsheet BGF Swiss Small & Midcap Opportunities Fund
    BLACKROCK GLOBAL FUNDS BGF Swiss Small & MidCap Opportunities Fund Class A2 CHF AGOSTO 2021 FICHA INFORMATIVA O Desempenho, a Discriminação da Carteira e as informações dos Activos Líquidos referem- Capital em risco. Todos os investimentos se à data de: 31/08/21. Todos os outros dados à data de: 09/09/21. financeiros comportam um elemento de risco. Os investidores devem ler o Prospeto e o Documento KIID antes de investir. Por conseguinte, o valor do seu investimento e o respetivo rendimento variarão e o montante RESUMO DO FUNDO do investimento inicial não é garantido. A estratégia de investimento deste fundo tem uma restrição de capacidade, o que significa que está fechado a novas subscrições. CARACTERÍSTICAS CHAVE Classe de activos Acções O Fundo Swiss Small & MidCap Opportunities visa maximizar a rentabilidade total. O Fundo Categoria Morningstar Switzerland Small/Mid-Cap Equity investe pelo menos 70% do total dos seus activos em acções de empresas de pequena e Data do Ínicio do Fundo 01/08/08 média capitalização domiciliadas, ou que exerçam a parte predominante da sua actividade Data de lançamento da económica, na Suíça. As empresas de pequena e média capitalização são consideradas como classe de acções 01/08/08 empresas que, na altura da compra, não são membros do Índice do Mercado Suíço. Moeda de negociação do fundo CHF Moeda de classe de acção CHF CRESCIMENTO HIPOTÉTICO DE 10.000 Dimensão total do fundo (AUM) 1,067.46 CHF Índice Referência Switzerland SPI Extra Index Domicílio Luxemburgo Tipo de fundo UCITS ISIN LU0376446257 Indicador Bloomberg BGSWOPA Tipo de Distribuição Sem distribuição Investimento Inicial Mínimo 5,000 USD* * ou moeda equivalente GESTÃO DE PORTEFÓLIO Christopher Sykes Fundo Índice referência Categoria de ações e Desempenho de referência apresentados em CHF.
    [Show full text]